IL113930A - Drug administration form for the controlled release controlled release of active substances in the gastrointestinal tract having a delayed pylorus passage - Google Patents

Drug administration form for the controlled release controlled release of active substances in the gastrointestinal tract having a delayed pylorus passage

Info

Publication number
IL113930A
IL113930A IL11393095A IL11393095A IL113930A IL 113930 A IL113930 A IL 113930A IL 11393095 A IL11393095 A IL 11393095A IL 11393095 A IL11393095 A IL 11393095A IL 113930 A IL113930 A IL 113930A
Authority
IL
Israel
Prior art keywords
controlled release
active substances
gastrointestinal tract
drug administration
administration form
Prior art date
Application number
IL11393095A
Other languages
English (en)
Other versions
IL113930A0 (en
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL113930A0 publication Critical patent/IL113930A0/xx
Publication of IL113930A publication Critical patent/IL113930A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IL11393095A 1994-06-07 1995-05-31 Drug administration form for the controlled release controlled release of active substances in the gastrointestinal tract having a delayed pylorus passage IL113930A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4419818A DE4419818C2 (de) 1994-06-07 1994-06-07 Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben

Publications (2)

Publication Number Publication Date
IL113930A0 IL113930A0 (en) 1995-08-31
IL113930A true IL113930A (en) 1999-10-28

Family

ID=6519958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11393095A IL113930A (en) 1994-06-07 1995-05-31 Drug administration form for the controlled release controlled release of active substances in the gastrointestinal tract having a delayed pylorus passage

Country Status (21)

Country Link
EP (1) EP0765158B1 (fr)
JP (1) JP3801200B2 (fr)
KR (1) KR100499898B1 (fr)
CN (1) CN1204878C (fr)
AT (1) ATE172875T1 (fr)
AU (1) AU702676B2 (fr)
CA (1) CA2192110C (fr)
CZ (1) CZ356696A3 (fr)
DE (2) DE4419818C2 (fr)
DK (1) DK0765158T3 (fr)
ES (1) ES2126287T3 (fr)
FI (1) FI118952B (fr)
HU (1) HU221675B1 (fr)
IL (1) IL113930A (fr)
MY (1) MY130546A (fr)
NO (1) NO965236L (fr)
NZ (1) NZ287884A (fr)
PL (1) PL317378A1 (fr)
SK (1) SK281043B6 (fr)
WO (1) WO1995033449A1 (fr)
ZA (1) ZA954650B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745722B2 (en) * 1996-09-07 2002-03-28 Gunther Beisel Product with extender effect
DE19745208A1 (de) * 1997-10-13 1999-04-15 Labtec Gmbh Mundfilm
DE19757298A1 (de) 1997-12-22 1999-06-24 Basf Ag Verfahren zur Herstellung von Polymerpulvern
DE19822278A1 (de) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
FR2840221B1 (fr) * 2002-06-04 2006-01-13 Backert Marie Elisabeth Cuine Film polymerique contenant des "actifs" destines a etre liberes dans un liquide
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
DE102011006844A1 (de) 2011-04-06 2012-10-11 Siemens Aktiengesellschaft Elektrische Maschine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624846A5 (en) * 1975-12-15 1981-08-31 Hoffmann La Roche Solid pharmaceutical unit dose form and process and apparatus for producing it
DE2746414A1 (de) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Mittel zum dosieren von stoffen und verfahren zu seiner herstellung
CA1273872A (fr) * 1985-05-10 1990-09-11 Larry J. Caldwell Dispositif liberant un medicament qui peut etre retenu dans l'estomac pendant une periode determinee
ES2019275B3 (es) * 1985-10-09 1991-06-16 Desitin Arzneimittel Gmbh Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
JPH03163011A (ja) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
GB9203474D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel composition

Also Published As

Publication number Publication date
ZA954650B (en) 1996-01-26
SK281043B6 (sk) 2000-11-07
NO965236D0 (no) 1996-12-06
DK0765158T3 (da) 1999-07-19
JP3801200B2 (ja) 2006-07-26
KR100499898B1 (ko) 2005-09-05
DE59504159D1 (de) 1998-12-10
CN1149826A (zh) 1997-05-14
ES2126287T3 (es) 1999-03-16
AU2674395A (en) 1996-01-04
MX9606146A (es) 1998-06-30
NO965236L (no) 1996-12-06
NZ287884A (en) 1997-10-24
CA2192110A1 (fr) 1995-12-14
WO1995033449A1 (fr) 1995-12-14
CN1204878C (zh) 2005-06-08
FI964885A0 (fi) 1996-12-05
DE4419818C2 (de) 1998-10-22
SK157396A3 (en) 1997-09-10
MY130546A (en) 2007-06-29
EP0765158B1 (fr) 1998-11-04
FI118952B (fi) 2008-05-30
IL113930A0 (en) 1995-08-31
FI964885L (fi) 1996-12-05
DE4419818A1 (de) 1995-12-14
CZ356696A3 (en) 1997-03-12
ATE172875T1 (de) 1998-11-15
HU221675B1 (hu) 2002-12-28
JPH10500974A (ja) 1998-01-27
EP0765158A1 (fr) 1997-04-02
HUT75862A (en) 1997-05-28
PL317378A1 (en) 1997-04-01
CA2192110C (fr) 2006-05-02
KR970703134A (ko) 1997-07-03
AU702676B2 (en) 1999-03-04
HU9603326D0 (en) 1997-01-28

Similar Documents

Publication Publication Date Title
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
NZ239574A (en) Delayed release capsules having a permeable wall with a hole and containing fluid-expandable material which pushes out first an inert substance then a drug-containing material
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
SG164281A1 (en) Controlled release preparation
DE69811278D1 (de) Gegen magensaft geschützte omeprazol-mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
DE69710757D1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
NO20035655L (no) Fremgangsmate for fremstilling av tabletter
AU3582689A (en) Gastric retention system for controlled drug release
NZ512683A (en) Taste-masked pharmaceutical particles that are suitable for making chewable tablets
CA2272442A1 (fr) Pastille pour la liberation modifiee de principes actifs dans le tractus gastro-intestinal
DE59803511D1 (de) Expandierbares gastroretentives therapie-system mit kontrollierter wirkstofffreisetzung im gastrointestinaltrakt
DE69836207D1 (de) Orale pharmazeutische zusammensetzungen mit reduzierter bitterkeit durch geschmacksmaskiermittel
IL113930A (en) Drug administration form for the controlled release controlled release of active substances in the gastrointestinal tract having a delayed pylorus passage
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
BG101080A (en) Medicamentous form of carbamasepin with delayed release of the active substance
DE68906132D1 (de) Flecainidacetat enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
SI0765158T1 (en) Active substance carrier for the controlled release of active substances in the gastro-intestinal tract with delayed passage through the pylorus
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
ES8500049A1 (es) Un metodo para fabricar un material aglomerado para absorcion por el tracto gastro-intestinal.
ES8603754A1 (es) Procedimiento de obtencion de particulas de 4-hidroxi-2-me- til-n-2-piridil-2h-1,2-benzotiazina-3-carboxamida-1,1-dioxi-do(piroxicam) recubiertas
JO1881B1 (en) Formula II for multi unit disc calibration
RU96102195A (ru) Лекарственное средство
IT1244037B (it) Forma farmaceutica a rilascio selettivo nel colon

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees